Is left ventricular hypertrabeculation/noncompaction a cardiac manifestation of Fabry's disease?

Zeitschrift fur Kardiologie

Volumn 92, Issue 11, 2003, Pages 966-969

  Stollberger C ^a,b   Finsterer, J ^b   Voigtlander T ^c   Slany, J ^b  

^a Krankenanstalt Rudolfstiftung ^*  (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiomyopathy; Echocardiography; Fabry's disease; Left ventricular hypertrabeculation noncompaction; Storage disease

Indexed keywords

ALPHA GALACTOSIDASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FABRY DISEASE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LEUKOCYTE;

ADULT; AGED; ALPHA-GALACTOSIDASE; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FABRY DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PAPILLARY MUSCLES;

EID: 0344010192     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-1018-0     Document Type: Article

References (13)

1. Beer G, Reinecke P, Gabbert HE, Hort W, Kuhn H (2002) Fabry disease in patients with hypertrophic cardiomyopathy. Z Kardiol 91:992-1002
2. Bleyl SB, Mumford BR, Brown-Harrison MC, Pagotto LT, Carey JC, Pysher TJ, Ward K, Chin TK (1997) Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet 72:257-265
3. Blum A, Ashkenazi H, Haromankov I, Khazim K, Sheiman J (2003) First-degree atrioventricular block and restrictive physiology as cardiac manifestations of Fabry's disease. South Med J 96:212-213
4. Doi Y, Toda G, Yano K (2003) Sisters with atypical Fabry's disease with complete atrioventricular block. Heart 89:e2
5. Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M (2002) Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol 40:1668-1674
6. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakaruba H, Tanaka H (1995) An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 333:288-293
7. Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, Elliott PM (2002) Prevalence of Anderson-Fabry disease in male patients with late on-set hypertrophic cardiomyopathy. Circulation 105:1407-1411
8. Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy an Fabry disease. A randomised controlled trial. JAMA 285:2743-2749
9. Senechal M, Germain DP (2003) Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients. Clin Genet 63:46-52
10. Stöllberger C, Finsterer J, Blazek G (2002) Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 90:899-902
11. Veinot JP (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy (Letter). Circulation 106:e73
12. Waldeck S (2003) PR interval and the response to enzyme-replacement therapy for Fabry's disease (Letter). N Engl J Med 348:1186-1187
13. Yoshitama T, Nakao S, Takenaka T, Teraguchi H, Sasaki T, Kodama C, Tanaka A, Kisanuki A, Tei C (2001) Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease. Am J Cardiol 87:71-75